We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Continued strong adoption of Invisalign Clear Aligners and iTero scanners is expected to contribute to Align Technology's (ALGN) third-quarter 2021 results.
The Dow and the S&P 500 ended near an all-time high on Wednesday, lifted by the Federal Reserve's latest Beige Book report that points to a modest growth pace of the US economy, and upbeat third-quarter earnings report.
Entasis' (ETTX) phase III ATTACK study achieves primary endpoint. The study evaluates its investigational combo drug SUL-DUR in infections caused by Acinetobacter baumannii.
The S&P 500 and Nasdaq recoded the largest four consecutive winning stretch since July, lifted by an encouraging third-quarter corporate earnings result.
United Therapeutics' (UTHR) new drug application for Tyvaso DPI to treat PAH & PH-ILD fails to secure approval from the FDA. The stock declines resultantly.
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Lowe's Companies, Inc. (LOW), and Starbucks Corporation (SBUX).
Radius (RDUS) reports positive top-line results from the ATOM study evaluating Tymlos (abaloparatide) subcutaneous injection for use in men with osteoporosis. The study met the primary endpoint.
medical: Archive
Let Go of These 4 Toxic Stocks Right Away
by Rimmi Singhi
Steer clear of toxic stocks like SRI, ILMN, TPIC and JD to safeguard your portfolio from losses.
SRIPositive Net Change ILMNNegative Net Change JDNegative Net Change TPICPositive Net Change
industrial-products internet medical
Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).
PFENegative Net Change BDXNegative Net Change TMONegative Net Change TDOCPositive Net Change
earnings medical medical-devices
Align Technology (ALGN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Continued strong adoption of Invisalign Clear Aligners and iTero scanners is expected to contribute to Align Technology's (ALGN) third-quarter 2021 results.
ALGNPositive Net Change HSICPositive Net Change WSTPositive Net Change PODDPositive Net Change
medical medical-devices
Stock Market News for Oct 21, 2021
by Zacks Equity Research
The Dow and the S&P 500 ended near an all-time high on Wednesday, lifted by the Federal Reserve's latest Beige Book report that points to a modest growth pace of the US economy, and upbeat third-quarter earnings report.
ABTPositive Net Change UNHPositive Net Change VZNegative Net Change NFLXPositive Net Change ANTMNegative Net Change PYPLNegative Net Change
communications medical tech-stocks
Should You Buy HCA Healthcare (HCA) Ahead of Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
HCANegative Net Change
earnings medical
STAAR Surgical (STAA) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.
STAAPositive Net Change
medical
ShockWave Medical (SWAV) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
ShockWave Medical (SWAV) has been struggling lately, but the selling pressure may be coming to an end soon.
SWAVPositive Net Change
medical
The Zacks Analyst Blog Highlights: Microsoft, Mastercard, Pfizer, PepsiCo and Merck
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Mastercard, Pfizer, PepsiCo and Merck
MSFTPositive Net Change MANegative Net Change PFENegative Net Change MRKNegative Net Change PEPNegative Net Change
finance medical tech-stocks
JNJ Posts Mixed Q3 Bag, Ups View: ETFs in Focus
by Sweta Killa
Johnson & Johnson (JNJ) continued its long streak of earnings beat but lagged the revenue estimates. The company lifted its full-year guidance.
JNJNegative Net Change XLVNegative Net Change IYHNegative Net Change IHEPositive Net Change IEIHPositive Net Change PINKPositive Net Change
earnings etfs medical
Entasis' (ETTX) Phase III Study on Infection Drug Meets Goal
by Zacks Equity Research
Entasis' (ETTX) phase III ATTACK study achieves primary endpoint. The study evaluates its investigational combo drug SUL-DUR in infections caused by Acinetobacter baumannii.
ENTAPositive Net Change XNCRPositive Net Change ZLABPositive Net Change ETTXPositive Net Change
medical
Abbott's (ABT) Q3 Earnings Beat Estimates, 2021 Guidance Up
by Zacks Equity Research
Abbott's (ABT) COVID-19 testing-related sales in Q3 increase on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.
ABTPositive Net Change OMCLPositive Net Change WSTPositive Net Change STAAPositive Net Change
earnings medical medical-devices
Should You Buy Quest Diagnostics (DGX) Ahead of Earnings?
by Zacks Equity Research
Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
DGXNegative Net Change
earnings medical
New Strong Sell Stocks for October 20th
by Zacks Equity Research
GEL, WWD, IBIO, SI, and ATEC have been added to the Zacks Rank #5 (Strong Sell) List on October 20, 2021.
SIPositive Net Change GELNegative Net Change WWDPositive Net Change ATECNegative Net Change IBIOPositive Net Change
finance medical
Stock Market News for Oct 20, 2021
by Zacks Equity Research
The S&P 500 and Nasdaq recoded the largest four consecutive winning stretch since July, lifted by an encouraging third-quarter corporate earnings result.
JNJNegative Net Change MRKNegative Net Change PGNegative Net Change PMNegative Net Change BIDUPositive Net Change
finance medical
Anthem's (ANTM) Q3 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter results reflect higher revenues and solid contribution from its segments.
MDPositive Net Change ACHCNegative Net Change ANTMNegative Net Change BHCNegative Net Change
medical
Zacks.com featured highlights include: Sanderson Farms, AutoNation, AllianceBernstein, Cross Country Healthcare and Revolve Group
by Zacks Equity Research
Zacks.com featured highlights include: Sanderson Farms, AutoNation, AllianceBernstein, Cross Country Healthcare and Revolve Group
ANPositive Net Change ABPositive Net Change SAFMPositive Net Change CCRNPositive Net Change RVLVPositive Net Change
auto-tires-trucks consumer-staples medical
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
by Zacks Equity Research
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
FLPositive Net Change HIBBPositive Net Change GPIPositive Net Change TECKNegative Net Change EHCPositive Net Change
medical retail
United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA (Revised)
by Zacks Equity Research
United Therapeutics' (UTHR) new drug application for Tyvaso DPI to treat PAH & PH-ILD fails to secure approval from the FDA. The stock declines resultantly.
MNKDPositive Net Change LLYNegative Net Change UTHRNegative Net Change XNCRPositive Net Change
biotechs medical
Markets Up on Strong Q3 Earnings: NFLX, UAL, ISRG After the Bell
by Mark Vickery
The Dow marked its fifth straight day higher, while the S&P 500 gained +0.74% and the Nasdaq +0.71% on the day.
UALPositive Net Change NFLXPositive Net Change ISRGNegative Net Change
earnings internet-content medical
Top Stock Reports for Oracle, Lowe's & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Lowe's Companies, Inc. (LOW), and Starbucks Corporation (SBUX).
GSPositive Net Change ADPPositive Net Change BDXNegative Net Change SBUXNegative Net Change LOWPositive Net Change ORCLNegative Net Change
business-services computers construction finance medical restaurants retail
What's in Store for HCA Healthcare's (HCA) Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 results are likely to reflect better revenues owing to higher patient volumes.
MDPositive Net Change HCANegative Net Change ACHCNegative Net Change BHCNegative Net Change
medical
3 Reasons to Hold on to Boston Scientific (BSX) Stock For Now
by Zacks Equity Research
Investors are optimistic about Boston Scientific (BSX) given its recent acquisitions and strength in the structural heart business.
BSXNegative Net Change MDTNegative Net Change EYEPositive Net Change BRBRPositive Net Change
medical medical-devices
Radius' (RDUS) Study on Tymlos for Osteoporosis in Men Meets Goal
by Zacks Equity Research
Radius (RDUS) reports positive top-line results from the ATOM study evaluating Tymlos (abaloparatide) subcutaneous injection for use in men with osteoporosis. The study met the primary endpoint.
FOLDPositive Net Change RDUSPositive Net Change ATNXNo Net Change FULCPositive Net Change
medical
Abbott's (ABT) Nutrition Arm in Focus on Real Madrid Alliance
by Zacks Equity Research
According to Abbott (ABT), the partnership is set to support education, sports and social welfare activities of at-risk children in 80 countries.
ABTPositive Net Change HSICPositive Net Change ALCNegative Net Change WSTPositive Net Change
immuno-therapy medical medical-devices
Valneva (VALN) Reports Positive Data From COVID Vaccine Study
by Zacks Equity Research
Valneva's (VALN) shares surge after its COVID vaccine demonstrates superiority over AstraZeneca's COVID vaccine in a phase III study.
AZNPositive Net Change PFENegative Net Change MRNAPositive Net Change VALNPositive Net Change
biofuels medical pharmaceuticals vaccines